BioCentury
ARTICLE | Company News

Chiesi, Vernalis deal

April 26, 2010 7:00 AM UTC

Vernalis disclosed in its FY09 earnings that it will return rights to Chiesi this quarter for V1512 after failing to partner the compound. Vernalis completed a Phase II trial of the combination of me...